Atopic Dermatitis Market Share, Trends, Size, Major Players And Forecast To 2033 | Sanofi SA, Meda AB, Regeneron Pharmaceuticals Inc., Novartis International AG, Pfizer Inc., AbbVie Inc

Spread the love

The atopic dermatitis global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Atopic Dermatitis Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size –
The atopic dermatitis market size has grown rapidly in recent years. It will grow from <b>$7.51 billion in 2023 to $8.7 billion in 2024 at a compound annual growth rate (CAGR) of 15.9%. The  growth in the historic period can be attributed to medical understanding and awareness, incidence and prevalence rates, patient advocacy and support, treatment options evolution, research and development.

The atopic dermatitis market size is expected to see rapid growth in the next few years. It will grow to <b>$15.27 billion in 2028 at a compound annual growth rate (CAGR) of 15.1%. The growth in the forecast period can be attributed to biologic therapies advancements, immunomodulators and small molecule drugs, pediatric-specific treatments, gene therapy and precision medicine, digital health integration. Major trends in the forecast period include technological advancements in topicals, pediatric ad care focus, environmental and allergen management, precision diagnosis tools.

Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/atopic-dermatitis-global-market-report

Scope Of Atopic Dermatitis Market
The Business Research Company’s reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Atopic Dermatitis Market Overview

Market Drivers –
The high prevalence of atopic dermatitis is expected to propel the growth of the atopic dermatitis market forward. Atopic dermatitis, also called eczema, is a skin condition that causes dryness and itchiness of the skin. The increasing prevalence of atopic dermatitis increases the need for diagnosis and treatment of the disease. For instance, according to the National Eczema Association, a US-based organization working to spread awareness related to eczema, in 2021, 31.6 million people in the US had some form of eczema, which was about 10% of the total population. Approximately 9.6 million children under the age of 18 had atopic dermatitis, and 80% of the individuals were affected by dermatitis before the age of 6 years. Therefore, the increasing prevalence of atopic dermatitis is driving the growth of the atopic dermatitis market.

Market Trends –
Product innovations are a key trend gaining popularity in the atopic dermatitis market. Major companies in the market are introducing innovative products to strengthen their market position. For instance, in June 2022, Regeneron Pharmaceuticals Inc. a US-based biotechnology company received FDA approval for Dupixent (dupilumab). Dupixent is used for children with moderate-to-severe atopic dermatitis, ages 6 months to 5 years. Topical corticosteroids can be used with or without dupixent. Dupixent functions by inhibiting the signaling of two major Type 2 inflammatory sources (IL-4 and IL-13), which are crucial in the development of eosinophilic esophagitis, prurigo nodularis, chronic rhinosinusitis with nasal polyposis, and asthma .

The atopic dermatitis market covered in this report is segmented –
1) By Drug Class: Corticosteroids, Emollients/Moisturizers, IL-4 and PDE4 Inhibitors, Calcineurin Inhibitors, Antibiotics, Other Drug Classes
2) By Mode of Administration: Topical, Injectable, Oral
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Get an inside scoop of the atopic dermatitis market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=8285&type=smp

Regional Insights –
North America was the largest region in the atopic dermatitis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atopic dermatitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies –
Major companies operating in the atopic dermatitis market report are Sanofi SA, Meda AB, Regeneron Pharmaceuticals Inc., Novartis International AG, Pfizer Inc., AbbVie Inc., Astellas Pharma Inc., Arcutis Biotherapeutics Inc., Asana Biosciences LLC, Dermavant Sciences Inc., Eli Lilly and Company, Galderma SA, Incyte Corporation, Bayer AG, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, F Hoffmann-La Roche AG, LEO Pharma A/S, Teva Pharmaceutical Industries Ltd., Mylan MV, Allergan plc, Encore Dermatology Inc., Menlo Therapeutics Inc., Johnson & Johnson, Merck & Co Inc., Roche Holding AG, Valeant Pharmaceuticals International Inc., Amgen Inc., AstraZeneca plc, Bristol-Myers Squibb Company, Eisai Co. Ltd., Gilead Sciences Inc., Ipsen Biopharmaceuticals Inc., Kyowa Kirin Co. Ltd., Mallinckrodt Pharmaceuticals Limited

Table of Contents
1. Executive Summary
2. Atopic Dermatitis Market Characteristics
3. Atopic Dermatitis Market Trends And Strategies
4. Atopic Dermatitis Market – Macro Economic Scenario
5. Global Atopic Dermatitis Market Size and Growth

….

31. Global Atopic Dermatitis Market Competitive Benchmarking
32. Global Atopic Dermatitis Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Atopic Dermatitis Market
34. Atopic Dermatitis Market Future Outlook and Potential Analysis
35. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model


Spread the love

About Top PR News

TopPRnews Leads Drives Search Engine Visibility For Your Press Release Content. Our Global Network Reaches Important Contacts, Media Partners And Websites And Journalists. Happy Postings! If You Have Any Queries Please Contact Official Mail At [[email protected]}

View all posts by Top PR News →